Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSpaulding Rehabilitation Hospital
About this trial
The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.
Eligibility criteria
Qualifiers
Able to provide informed consent to participate in the study
Subjects between 18 to 80 years old
Having symptomatic CTS spreading within or beyond the median nerve distribution (demonstrating 'extra-median spread'), involving at least 1 wrist, with chronic pain as defined by International Association for the Study of Pain (existing pain for at least 6 months and having pain on at least half the days in the past 6 months with an average of at least a 3 on a 0-10 VAS scale).
Pain resistant to first line therapies of chronic pain (pain still present at lower levels most of the time following therapy)
Disqualifiers
Subject is pregnant
intracranial metal implant
implanted brain medical devices
History of alcohol or drug abuse within the past 6 months as self-reported
Trial design
Treatments tested in this trial
- transcranial Direct Current Stimulation (tDCS)
- Transcranial Ultrasound (TUS)
Treatment groups
95 Participants
are divided into 2 treatment groupsSponsors and collaborators
Spaulding Rehabilitation Hospital
Lead sponsor
Highland Instruments, Inc.
Collaborator
Source ClinicalTrials.gov